Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 122279
Published online Nov 27, 2026. doi: 10.4240/wjgs.122279
Published online Nov 27, 2026. doi: 10.4240/wjgs.122279
Figure 1 Cumulative recurrence-free survival in patients with hepatocellular carcinoma after resection based on albumin-bilirubin grade.
ALBI: Albumin-bilirubin.
Figure 2 Nomogram for predicting postoperative recurrence-free survival in patients with hepatocellular carcinoma.
AFP: Preoperative alpha-fetoprotein; ALBI: Albumin-bilirubin.
Figure 3 Time-dependent receiver operating characteristic curves for recurrence-free survival prediction.
A: Training set; B: Validation set. AUC: Area under the curve.
Figure 4 Calibration curves for predicting recurrence-free survival.
A: Training set for 1- and 2-year recurrence-free survival; B: Validation set for 1- and 2-year recurrence-free survival. RFS: Recurrence-free survival.
- Citation: Cong LY, Ma LY, Hong X, Geng GL, Fan BF. Construction and validation of a prognostic prediction model based on albumin-bilirubin grade after resection of hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(11): 122279
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/122279.htm
- DOI: https://dx.doi.org/10.4240/wjgs.122279